Upstream Bio, Inc.

Ownership Transactions Reported by 13 Insiders

Industry
Pharmaceutical Preparations
Location
460 Totten Pond Road, Suite 420, Waltham, MA

There are no Buy or Sell transactions made by insiders since 10/30/2023

Upstream Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Gray CFO and COO Oct 10, 2024
Erez Chimovits Director, 10%+ Owner Oct 15, 2024
Everett Rand Sutherland Chief Executive Officer, Director Oct 10, 2024
Ronald C. Renaud JR Director Oct 10, 2024
Orbimed Advisors Llc Director, 10%+ Owner Oct 15, 2024
Harold Edward Fleming Director Oct 10, 2024
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10%+ Owner Oct 15, 2024
Aaron Deykin Chief Medical Officer Oct 10, 2024
Liam Ratcliffe Director Oct 10, 2024
Marcella K. Ruddy Director Oct 10, 2024
Adam Houghton Chief Business Officer Oct 10, 2024
AI Upstream LLC 10%+ Owner Oct 15, 2024
Daniella Beckman Director Oct 10, 2024

Recent Insider Transactions by Companies or Individuals for Upstream Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.